Bristol-Myers Squibb
Executive Summary
Company licenses ultrasound contrast agent SonoRx (simethicone- coated cellulose) from Tucson, Ariz.-based ImRx Pharmaceutical. Bristol says it will file an IND for SonoRx this year and expects to complete clinicals in 1994.